Evidence map›Paper›PMID 34579023›Full record

ReviewNutrients2021

Diet in Intestinal Fibrosis: A Double-Edged Sword.

Rachel Marion-Letellier, Mathilde Leboutte, Asma Amamou, Maitreyi Raman, Guillaume Savoye, Subrata Ghosh

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Rachel Marion-LetellierUNIROUEN, INSERM UMR 1073 Nutrition, Inflammation and Gut-Brain Axis, Normandie University, 76183 Rouen, France.ORCID 0000-0002-3006-5943
Mathilde LeboutteUNIROUEN, INSERM UMR 1073 Nutrition, Inflammation and Gut-Brain Axis, Normandie University, 76183 Rouen, France.ORCID 0000-0002-7352-8960
Asma AmamouAPC Microbiome Ireland, Biosciences Building, University College Cork, Cork, Ireland.
Maitreyi RamanDivision of Gastroenterology, University of Calgary, Calgary, AB T2N 4N1, Canada.ORCID 0000-0002-9129-3632
Guillaume SavoyeUNIROUEN, INSERM UMR 1073 Nutrition, Inflammation and Gut-Brain Axis, Normandie University, 76183 Rouen, France.
Subrata GhoshAPC Microbiome Ireland, Biosciences Building, University College Cork, Cork, Ireland.
Inserm · FRUniversity College Cork · IEUniversity of Calgary · CA

Funding

Association Francois Aupetit NARégion Normandie NASociété Francophone Nutrition Clinique et Métabolisme NA
6 · The paper itself

Abstract

The natural history of inflammatory bowel diseases, especially Crohn's disease, is frequently complicated by intestinal fibrosis. Because of the lack of effective treatments for intestinal fibrosis, there is an urgent need to develop new therapies. Factors promoting intestinal fibrosis are currently unclear, but diet is a potential culprit. Diet may influence predisposition to develop intestinal fibrosis or alter its natural history by modification of both the host immune response and intestinal microbial composition. Few studies have documented the effects of dietary factors in modulating IBD-induced intestinal fibrosis. As the mechanisms behind fibrogenesis in the gut are believed to be broadly similar to those from extra-intestinal organs, it may be relevant to investigate which dietary components can inhibit or promote fibrosis factors such as myofibroblasts progenitor activation in other fibrotic diseases.

Indexed as

DietFibrosisHumansInflammatory Bowel DiseasesIntestinesCrohn’s diseasedietfibrosisgut microenvironment

Identifiers

PMID34579023
PMCPMC8470259
OpenAlexW3196355496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.